Pharmaceutical preparation and method for its manufacture

US11382865B2 · kind B2 · utility

Assignee

• Bayer Animal Health GmbH · DE

Inventors

• Venkata-Rangarao Kanikanti · Leverkusen, DE
• Patrick Billian · Brieselang, DE

Key dates

• Filing date: Nov 30, 2017
• Grant date: Jul 12, 2022
• Expiry date: Nov 30, 2037

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P43/00
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The present invention refers to a pharmaceutical preparation (10) comprising a first pharmaceutical composition having a matrix material and pharmaceutically active ingredients distributed within the matrix material, wherein the first pharmaceutical composition comprises Praziquantel, Pyrantel and Febantel as pharmaceutical active ingredients, wherein the preparation (10) comprises a second pharmaceutical composition having a matrix material and at least one of avermectins and milbemycins such as Moxidectin as pharmaceutically active ingredient distributed within the matrix material, wherein the preparation (10) is provided in a multi-layer structure such, that the first composition is provided in a first layer (12) and the second composition is provided in a second layer (14), wherein the first layer (12) and the second layer (14) are separated by a barrier layer (16) being provided between the first layer (12) and the second layer (14).